The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Isolation and characterization
Turksen, K. (2006) · Humana Press eBooks · Cited by 2,146
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Eriksson, B. I., Borris, L. C., Friedman, R. J., Haas, S., Huisman, M. V., Kakkar, A. K., Bandel, T. J., Beckmann, H., Muehlhofer, E., Misselwitz, F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800374 · Cited by 1,433
Self-citationRivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Lassen, M. R., Ageno, W., Borris, L. C., Lieberman, J. R., Rosencher, N., Bandel, T. J., Misselwitz, F., & Turpie, A. G. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa076016 · Cited by 1,295
Self-citationEriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Prins, M. H., Hettiarachchi, R., Hantel, S., Schnee, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61445-7 · Cited by 1,116
Kakkar, A. K., Brenner, B., Dahl, O. E., Eriksson, B. I., Mouret, P., Muntz, J., Soglian, A. G., Pap, Á. F., Misselwitz, F., & Haas, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60880-6 · Cited by 1,070
Self-citationTurpie, A. G., Lassen, M. R., Davidson, B. L., Bauer, K. A., Gent, M., Kwong, L. M., Cushner, F. D., Lotke, P. A., Berkowitz, S. D., Bandel, T. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60734-0 · Cited by 981
Self-citationERIKSSON, B. I., DAHL, O. E., ROSENCHER, N., KURTH, A. A., VAN DIJK, C. N., FROSTICK, S. P., KÄLEBO, P., CHRISTIANSEN, A. V., HANTEL, S., HETTIARACHCHI, R., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02748.x · Cited by 979
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Warkentin, T. E., Greinacher, A., Koster, A., & Lincoff, A. M. (2008) · Chest · doi:10.1378/chest.08-0677 · Cited by 816
Lassen, M. R., Raskob, G. E., Gallus, A., Pineo, G., Chen, D., & Hornick, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62125-5 · Cited by 777
Hirsh, J., Bauer, K. A., Donati, M. B., Gould, M., Samama, M. M., & Weitz, J. I. (2008) · Chest · doi:10.1378/chest.08-0689 · Cited by 755
Turpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
Lassen, M. R., Raskob, G. E., Gallus, A., Pineo, G., Chen, D., & Portman, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810773 · Cited by 695
Mega, J., Braunwald, E., Mohanavelu, S., Burton, P., Poulter, R., Misselwitz, F., Hricak, V, Barnathan, E., Bordes, P., Witkowski, A., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60738-8 · Cited by 688
Self-citationBauer, K. A., Eriksson, B. I., Lassen, M. R., & Turpie, A. G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011099 · Cited by 666
KUBITZA, D., BECKA, M., VOITH, B., ZUEHLSDORF, M., & WENSING, G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.011 · Cited by 649
Self-citationKubitza, D., Becka, M., Wensing, G., Voith, B., & Zuehlsdorf, M. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0043-5 · Cited by 640
Self-citationEriksson, B. I., Bauer, K. A., Lassen, M. R., & Turpie, A. G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011100 · Cited by 631
(2009) · The Journal of Arthroplasty · doi:10.1016/j.arth.2008.01.132 · Cited by 631
Saito, H., Maruyama, I., Shimazaki, S., Yamamoto, Y., Aikawa, N., Ohno, R., Hirayama, A., Matsuda, T., Asakura, H., Nakashima, M., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02267.x · Cited by 603
PERZBORN, E., STRASSBURGER, J., WILMEN, A., POHLMANN, J., ROEHRIG, S., SCHLEMMER, K.-H., & STRAUB, A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01166.x · Cited by 590
Self-citationGenetic Determinants of Response to Warfarin during Initial Anticoagulation
Schwarz, U. I., Ritchie, M. D., Bradford, Y., Li, C., Dudek, S. M., Frye-Anderson, A., Kim, R. B., Roden, D. M., & Stein, C. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708078 · Cited by 577
What is all that thrombin for?
Mann, K. G., Brummel, K., & Butenas, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00298.x · Cited by 560
Turpie, A. G., Bauer, K. A., Eriksson, B. I., & Lassen, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08648-8 · Cited by 537
COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXES
Mann, K. G., Jenny, R. J., & Krishnaswamy, S. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.004411 · Cited by 536
THE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
The Dynamics of Thrombin Formation
Mann, K. G., Butenas, S., & Brummel, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000046238.23903.fc · Cited by 520
Reactivation of Unstable Angina after the Discontinuation of Heparin
Théroux, P., Waters, D., Lam, J., Juneau, M., & McCans, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270301 · Cited by 464
APPRAISE Steering Committee and Investigators (2009) · Circulation · doi:10.1161/circulationaha.108.832139 · Cited by 461
Lopes, R. D., Alexander, J. H., Al-Khatib, S. M., Ansell, J., Diaz, R., Easton, J. D., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.07.035 · Cited by 457
Roehrig, S., Straub, A., Pohlmann, J., Lampe, T., Pernerstorfer, J., Schlemmer, K.-H., Reinemer, P., & Perzborn, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050101d · Cited by 436
Self-citationKubitza, D., Becka, M., Mueck, W., Halabi, A., Maatouk, H., Klause, N., Lufft, V., Wand, D. D., Philipp, T., & Bruck, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03753.x · Cited by 432
Self-citationPinto, D. J. P., Orwat, M. J., Koch, S., Rossi, K. A., Alexander, R. S., Smallwood, A., Wong, P. C., Rendina, A. R., Luettgen, J. M., Knabb, R. M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070245n · Cited by 402
Buller, H. R., Lensing, A. W. A., Prins, M. H., Agnelli, G., Cohen, A., Gallus, A. S., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008) · Blood · doi:10.1182/blood-2008-05-160143 · Cited by 342
Self-citationConnolly, S., Patel, I., Salazar, D., Rohatagi, S., Mendell, J., Kastrissios, H., Jin, J., Kunitada, S., & Weitz, J. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0066 · Cited by 341
Agnelli, G., Gallus, A., Goldhaber, S. Z., Haas, S., Huisman, M. V., Hull, R. D., Kakkar, A. K., Misselwitz, F., & Schellong, S. (2007) · Circulation · doi:10.1161/circulationaha.106.668020 · Cited by 337
Self-citationEriksson, B. I., Borris, L. C., Dahl, O. E., Haas, S., Huisman, M. V., Kakkar, A. K., Muehlhofer, E., Dierig, C., Misselwitz, F., & Kälebo, P. (2006) · Circulation · doi:10.1161/circulationaha.106.642074 · Cited by 335
Self-citationIdraparinux versus Standard Therapy for Venous Thromboembolic Disease
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa064247 · Cited by 335
Kubitza, D., Becka, M., Zuehlsdorf, M., & Mueck, W. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006296058 · Cited by 334
Self-citationTURPIE, A. G. G., FISHER, W. D., BAUER, K. A., KWONG, L. M., IRWIN, M. W., KÄLEBO, P., MISSELWITZ, F., & GENT, M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01602.x · Cited by 302
Self-citationERIKSSON, B. I., BORRIS, L., DAHL, O. E., HAAS, S., HUISMAN, M. V., KAKKAR, A. K., MISSELWITZ, F., & KÄLEBO, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01657.x · Cited by 302
Self-citationFURUGOHRI, T., ISOBE, K., HONDA, Y., KAMISATO‐MATSUMOTO, C., SUGIYAMA, N., NAGAHARA, T., MORISHIMA, Y., & SHIBANO, T. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03064.x · Cited by 301
WONG, P. C., CRAIN, E. J., XIN, B., WEXLER, R. R., LAM, P. Y. S., PINTO, D. J., LUETTGEN, J. M., & KNABB, R. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02939.x · Cited by 300
Kubitza, D., Becka, M., Roth, A., & Mueck, W. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802361499 · Cited by 268
Self-citationStassen, J.-M., Priepke, H., Ries, U. J., Hauel, N., & Wienen, W. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-03-0183 · Cited by 250
Mueck, W., Eriksson, B. I., Bauer, K. A., Borris, L., Dahl, O. E., Fisher, W. D., Gent, M., Haas, S., Huisman, M. V., Kakkar, A. K., et al. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847030-00006 · Cited by 243
Self-citationTurpie, A. G. G. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.139402 · Cited by 224
Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222
A regulatory viewpoint on transporter-based drug interactions
Zhang, L., Zhang, Y. (. )., Strong, J. M., Reynolds, K. S., & Huang, S.-M. (2008) · Xenobiotica · doi:10.1080/00498250802017715 · Cited by 188
Gold, H. K., Torres, F. W., Garabedian, H. D., Werner, W., Jang, I.-K., Khan, A., Hagstrom, J. N., Yasuda, T., Leinbach, R. C., Newell, J. B., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90222-m · Cited by 180
Eriksson, B. I., Kakkar, A. K., Turpie, A. G. G., Gent, M., Bandel, T.-J., Homering, M., Misselwitz, F., & Lassen, M. R. (2009) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.91b5.21691 · Cited by 177
Self-citationFactor Xa or thrombin: is factor Xa a better target?
ANSELL, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02473.x · Cited by 170
Eikelboom, J. W., O'Donnell, M., Yusuf, S., Diaz, R., Flaker, G., Hart, R., Hohnloser, S., Joyner, C., Lawrence, J., Pais, P., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.08.026 · Cited by 163
Nunnelee, J. D. (2011) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2011.03.002 · Cited by 161
GEROTZIAFAS, G. T., ELALAMY, I., DEPASSE, F., PERZBORN, E., & SAMAMA, M. M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02429.x · Cited by 159
Self-citationKubitza, D., Becka, M., Mueck, W., & Zuehlsdorf, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02776.x · Cited by 158
Self-citationHirsh, J., O'Donnell, M. J., & Weitz, J. I. (2004) · Blood · doi:10.1182/blood-2003-12-4195 · Cited by 157
Antistasin, a Leech-derived Inhibitor of Factor Xa
Dunwiddie, C. T., Thornberry, N. A., Bull, H. G., Sardana, M. K., Friedman, P. A., Jacobs, J., & Simpson, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84761-0 · Cited by 151
Cohen, A. T., Eriksson, B. I., Puskas, D., Shi, M., Bocanegra, T. S., Weitz, J. I., & Raskob, G. E. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-02-0142 · Cited by 146
Eriksson, B. I., Borris, L. C., Dahl, O. E., Haas, S. K., Huisman, M. V., Kakkar, A. K., Misselwitz, F., Muehlhofer, E., & Kälebo, P. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.12.025 · Cited by 145
Self-citationGraff, J., von Hentig, N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H., & Harder, S. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007302952 · Cited by 139
Self-citationSabatine, M. S., Antman, E. M., Widimský, P., Ebrahim, I. O., Kiss, R. G., Saaiman, A., Polášek, R., Contant, C. F., McCabe, C. H., & Braunwald, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61454-9 · Cited by 139
Fuji, T., FUJITA, S., TACHIBANA, S., & Kawai, Y. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04021.x · Cited by 137
Drug interactions evaluation: An integrated part of risk assessment of therapeutics
Zhang, L., Reynolds, K. S., Zhao, P., & Huang, S.-M. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.016 · Cited by 125
Zafar, M. U., Vorchheimer, D. A., Gaztañaga, J., Velez, M., Yadegar, D., Moreno, P., Kunitada, S., García‐Pagán, J. C., Fuster, V., & Badimon, J. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0312 · Cited by 124
Maignan, S., Guilloteau, J. P., Choi-Sledeski, Y. M., Becker, M. R., Ewing, W. R., Pauls, H. W., Spada, A. P., & Mikol, V. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203837 · Cited by 123
Pharmacokinetics of BAY 59-7939 – an oral, direct Factor Xa inhibitor – in rats and dogs
Weinz, C., Buetehorn, U., Daehler, H.-P., Kohlsdorfer, C., Pleiß, U., Sandmann, S., Schlemmer, K., Schwarz, T., & Steinke, W. (2005) · Xenobiotica · doi:10.1080/00498250500250493 · Cited by 100
Crystal Structures of Two Potent Nonamidine Inhibitors Bound to Factor Xa ,
Adler, M., Kochanny, M. J., Ye, B., Rumennik, G., Light, D. R., Biancalana, S., & Whitlow, M. D. (2002) · Biochemistry · doi:10.1021/bi0264061 · Cited by 93
Role of Thrombin Compared With Factor Xa in the Procoagulant Activity of Whole Blood Clots
Prager, N. A., Abendschein, D. R., McKenzie, C. R., et al. (1995) · Circulation · doi:10.1161/01.cir.92.4.962 · Cited by 90
Thrombin physiology and pathophysiology
Licari, L. G., & Kovacic, J. P. (2009) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2009.00383.x · Cited by 82
McKenzie, C. R., Abendschein, D. R., & Eisenberg, P. R. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.10.1285 · Cited by 66
Recombinant human activated protein C: current insights into its mechanism of action
Levi, M. M., & van der Poll, T. (2007) · Critical Care · doi:10.1186/cc6154 · Cited by 64
Review of the rebound phenomenon in new anticoagulant treatments
Hermans, C. R. J. R., & Claeys, D. A. B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x89801 · Cited by 60
Eriksson, B. I., Turpie, A. G. G., Lassen, M. R., Prins, M. H., Agnelli, G., Kälebo, P., Wetherill, G., Wilpshaar, J., & Meems, L. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03748.x · Cited by 59
Kubitza, D., Mueck, W., & Becka, M. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00006 · Cited by 53
Self-citationApixaban, an oral, direct inhibitor of activated Factor Xa.
Shantsila, E., & Lip, G. Y. H. (2008) · PubMed · Cited by 51
Rivaroxaban, an oral direct factor Xa inhibitor
Piccini, J. P., Patel, M. R., Mahaffey, K. W., Fox, K. A. A., & Califf, R. M. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.6.925 · Cited by 48
Visions & Reflections Factor Xa - a promising target for drug development
Kaiser, B. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8415-9 · Cited by 38
Becker, S., Simpson, J. C., Pepperkok, R., Heinz, S., Herder, C., Grez, M., Seifried, E., & Tonn, T. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-06-0360 · Cited by 35
Prothrombin Complex Concentrate Reverses the Effects of High-Dose Rivaroxaban in Rats
Perzborn, E., Trabandt, A., Selbach, K., & Tinel, H. (2009) · Cited by 33
Self-citationBergqvist, D. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.4.365 · Cited by 28
Kakkar, A. K., Brenner, B., Dahl, O. E., Eriksson, B. I., Mouret, P., Muntz, J., Bandel, T. J., Misselwitz, F., & Haas, S. K. (2007) · Blood · doi:10.1182/blood.v110.11.307.307 · Cited by 19
Self-citationBuller, H. R. (2010) · Blood · doi:10.1182/blood.v116.21.187.187 · Cited by 7
Cited by
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
Beno, B. R., Yeung, K.-S., Bartberger, M. D., Pennington, L. D., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501853m · Cited by 772
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Mueck, W., Stampfuss, J., Kubitza, D., & Becka, M. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0100-7 · Cited by 612
Self-citationRivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1808848 · Cited by 345
Frendl, G., Sodickson, A. C., Chung, M. K., Waldo, A. L., Gersh, B. J., Tisdale, J. E., Calkins, H., Aranki, S., Kaneko, T., Cassivi, S., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.036 · Cited by 343
Metadata
- Authors
- Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., & Misselwitz, F.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-12-17
- Volume
- 10
- Issue
- 1
- Pages
- 61-75
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2153438515
- Cited by
- 297
- References
- 93
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.